Novartis bags FDA priority review in tight lung cancer race against Merck KGaA
Novartis bags FDA priority review in tight lung cancer race against Merck KGaA
Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook
Liver Cancer Insight Report: Current Therapies, Drug Pipeline and Outlook
Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes
Biotech Q4 Earnings Synopsis: Major Restructuring and Overall Growth Are Themes
Top Companies in Pharm Country Ranked by Revenue
Κάντε like στη σελίδα μας στο facebook για να μαθαίνετε πρώτοι όλα τα νέα!! Pharm Country denotes the hotbed of biotech and biopharmaceutical companies that are located in … Continue Reading Top Companies in Pharm Country Ranked by Revenue
Merck’s Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?
Merck’s Keytruda is bound for new bladder cancer territory. But can it hold up against gene therapy?
Merck’s Keytruda: A Deep Dive
Merck’s Keytruda: A Deep Dive
10 Takeover Targets to Watch This Fall
10 Takeover Targets to Watch This Fall
Θετικές εξελίξεις στην πολλαπλή σκλήρυνση
Θετικές εξελίξεις στην πολλαπλή σκλήρυνση
Roche’s Tecentriq scores solo win in lung cancer. But can it challenge Merck’s Keytruda?
Roche’s Tecentriq scores solo win in lung cancer. But can it challenge Merck’s Keytruda?
Roche’s Tecentriq, on an EU hot streak, bags 2 new lung cancer approvals
Roche’s Tecentriq, on an EU hot streak, bags 2 new lung cancer approvals
Keytruda Approvals: A Timeline
Keytruda Approvals: A Timeline
Πώς θα κινηθεί η αγορά γονιδιακής επεξεργασίας
Πώς θα κινηθεί η αγορά γονιδιακής επεξεργασίας
AstraZeneca’s Imfinzi tees up small cell lung cancer fight with Roche
AstraZeneca’s Imfinzi tees up small cell lung cancer fight with Roche
FDA Action Alert: Merck, Agios and AMAG Pharma
FDA Action Alert: Merck, Agios and AMAG Pharma
Απεβίωσε ο Γιάννης Βλόντζος
Απεβίωσε ο Γιάννης Βλόντζος
Καινοτόμος θεραπεία για την πολλαπλή σκλήρυνση
Καινοτόμος θεραπεία για την πολλαπλή σκλήρυνση
